Annual Meeting

Watch On-Demand Sessions from ASGCT 2020

ASGCT Staff - May 13, 2020

Miss a session at ASGCT? Recordings from ASGCT's 23rd Annual Meeting are now available for registered attendees to watch on-demand through Sunday, June 14!

ASGCT is excited to offer on-demand service to all registered attendees at the 23rd Annual Meeting! The session archive will be updated throughout the meeting as recordings are prepared for re-broadcast, and will be available online through June 14.

Sessions are consistently processing through the Annual Meeting virtual environment, and this list below will be updated in as close to real time as possible. ASGCT staff are publishing more sessions as they become available. Presentations approved by speakers from all sessions will be included in this collection.

Tip: Looking for a specific session in the list below? Search the text of the page by pressing Ctrl+F and typing the session name.

Monday, May 11


Clinical Trials Training I

CAR T-Cell and Immune Effectors Workshop

Stem Cell Therapies Workshop

Commercialization I Workshop


Oncolytic Viruses Workshop

Gene Editing Workshop
A recording error has limited the amount of this session available on-demand.

Viral Vector Development Workshop

Clinical Trials Training II

Commercialization II Workshop

Tuesday, May 12

8 a.m.

The Golden Age of Gene Therapy: Past, Present and Future Perspectives

Advances in Allogeneic and Off-the-Shelf Hematopoietic Cell Therapies - Organized by the Hematologic and Immunologic Gene and Cell Therapy Committee

Advances in Therapeutic RNAi - Organized by the Oligonucleotide and RNAi Therapeutics Committee

Developing New Therapies for Children with Metabolic Disorders

Growing Gene and Cell Therapy (GGACT): An NCATS-funded collaborative effort to support Development of academic clinical trials for rare diseases

Pharmacovigilance and Long Term Follow up of Gene Therapies in the Post-Approval World - Organized by the Regulatory Affairs Committee

Successes in Gene Therapy for Musculoskeletal Disease - Organized by the Musculo-Skeletal Gene & Cell Therapy Committee

10:15 a.m.

Gene Therapy for the Special Senses

Genome Editing: Preclinical & Rare Disease

Cancer - Targeted Gene and Cell Therapy

Advances in AAV Vector Engineering

CAR T-Cells Targeting Solid Tumors

CAR T-Cell Therapies I

Assay Development

Immune Responses Against AAV Vectors

New Developments in Particles, Transfer Methods and Vectors for Gene Delivery - Organized by the Physical Delivery, Therapeutics & Vector Development Committee

Oligonucleotide Therapies for Genetic Diseases

Vector and Cell Engineering, Production or Manufacturing I

12 p.m.

Tools and Technologies Forum 1

1:30 p.m.

Adeno-associated Virus (AAV) Vectors - From Basic Biology to Vector Application

Bioinformatics: Artificial Intelligence (AI) takes Gene Therapy to the Next Level

Engineered T cell Therapies for Malignancies

Gene Editing with CRISPR/Cas9, Discovery to Application

“Off the Shelf” Cell Therapies

Updates on Immunogenicity against AAV and Cas9

Building Robust Animal Models for Preclinical Testing Gene and Immune Therapies for Humans

Synthetic Biology Meets Immunology: DNA and RNA Tools

3:30/3:45 p.m.

AAV Vector Biology: New Insights

AAV Gene Delivery for CNS Disorders

Antiviral Immunotherapy

AAV Vectors Preclinical and Proof-of-Concept Studies in Optimizing the Toolbox

CAR T and Other Engineered T Cells Targeting Hematological Malignancies

Hematopoietic Cell Therapies

HSPC Gene Therapies for Blood and Immune Disorders

Oligonucleotide Therapies for Acquired Diseases

Tools and Technologies Forum 2

Vector and Cell Engineering, Production or Manufacturing II

Wednesday, May 13

8 a.m.

Career Development in Academia and Industry

Cell-based Therapies for Eye and Nervous System Disorders: Translation from Research to Early Clinical Stages

Globalization Roadmap for Cell and Gene Therapies - Organized by the Commercialization Committee

Social, Ethical, and Scientific Perspectives on Germline Gene Editing - Organized by the Ethics and Government Relations Committees

Strategies for Preparing Synthetic Vectors for Clinical Application

Targeting the Lung: Vectors and Stem Cells - Organized by the Respiratory & GI Tract Gene & Cell Therapy Committee

10:15 a.m.

George Stamatoyannopoulos Memorial Lecture & Presentation of the Excellence in Research Awards

12 p.m.

Industry Sponsored Symposium: Cytvia

Industry Sponsored Symposium: Pall Biotech

Molecular Therapy Lunch Session

1:30 p.m.

Outstanding New Investigator Symposium

3:30/3:45 p.m.

AAV Vectors – Clinical Studies II

Applications of Physical, Chemical and Exosomal Delivery

Clinical Gene Therapies for Inborn Errors of Metabolism

Controlling AAV Gene Expression: Shifting Paradigms

Evaluating Genome Editing Activity and Precision

HSPC Gene Therapies for Hemoglobin Disorders

Musculo-skeletal Diseases I

Preclinical Large Animal Studies for Neurologic Diseases

Tools and Technologies Forum 4

Vector and Cell Engineering, Production or Manufacturing III

Thursday, May 14

8 a.m.

Clearing the Path to an IND: How we succeeded

Latest Advances in Cancer Gene and Cellular Therapies

Vector Development, Clinical Implementation, and Corporate Connections

10:20 a.m.

Outstanding Achievement Award Lecture & Presentation & Sonia Skarlatos Public Service Award

12 p.m.

Characterizing and Minimizing Genome Editing Off-Target Effects

Industry Sponsored Symposium: GenScript USA Inc.

Industry Sponsored Symposium: Terumo BCT

Tools and Technologies Forum 5

3:45 p.m.

AAV Vector Development: Towards Translation

AAV Vectors Preclinical and Proof-of-Concept Studies in Systemic Diseases

Viral Vector Development: RNA Virus Vectors

Friday, May 15

8 a.m.

2019 Career Development Award Recipients

Accessing Virus Vectors for Non-clinical and Clinical Gene Therapy Studies

Challenges and Future Directions in Cardiovascular Gene and Cell Therapy - Organized by the Cardiovascular Gene & Cell Therapy Committee

Challenges and Possible Solutions in Infectious Diseases - Organized by the Infectious Diseases and Vaccines Committee

Clinical Trials Spotlight Symposium

Gene and Cell Therapeutic Strategies to Treat Disorders of the CNS – An International Perspective

Gene Editing: Emerging New Technologies and Unbiased Assessment of On and Off Target Genome Alteration - Organized by the Genome Editing Committee

Stem Cell-derived Organoids - Organized by the Stem Cell Committee

10:15 a.m.

AAV Vectors - Clinical Studies I

AAV Vectors Preclinical and Proof-of-Concept Studies in CNS Disorders

Cancer - Oncolytic Viruses

Cancer Immunotherapy: Clinical Results

Gene Regulation and Delivery Technologies

Gene Therapy for Inborn Errors of Metabolism: New Approaches

Physical, Chemical and Exosomal Gene DeliveryTechnical Advances in Cell Therapies

Vector and Cell Engineering, Production or Manufacturing V

Share This Page

Related Articles

Annual Meeting

Early Data Demonstrate Strengths of Gene Therapy Approaches for Sanfilippo Syndrome

Karen Bulaklak, Ph.D. - May 26, 2020
Annual Meeting

The New Look of the Presidential Symposium

Kenji Rowel Lim - May 18, 2020
Annual Meeting

How to Navigate the 23rd Annual Meeting

ASGCT Staff - May 11, 2020
Annual Meeting

Here's How to Access the 23rd Annual Meeting

ASGCT Staff - May 11, 2020